News
Better Buy: Gilead Sciences, Inc. vs. Amgen
Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD) are central figures within the biotech landscape. However, these two titans of the industry are both in the process of refreshing their....
Better Buy: Gilead Sciences, Inc. vs. Amgen
Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD) are central figures within the biotech landscape. However, these two titans of the industry are both in the process of refreshing their....
Better Buy: Gilead Sciences, Inc. vs. Amgen
Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD) are central figures within the biotech landscape. However, these two titans of the industry are both in the process of refreshing their....
3 Small, Profitable Biotechs With Fantastic Growth
Investors could be forgiven for shying away from the stocks of small biotechs. Not only is the complex technology behind their products almost impossible for most of us to understand, the majority....
Why Exactech Skyrocketed 31% Today
After agreeing to be taken private by global alternative asset manager TPG Capital, Exactech (NASDAQ: EXAC) jumped 31% today.Exactech makes orthopedic implant devices and related surgical....
Why Exactech Skyrocketed 31% Today
After agreeing to be taken private by global alternative asset manager TPG Capital, Exactech (NASDAQ: EXAC) jumped 31% today.Exactech makes orthopedic implant devices and related surgical....
Why MiMedx Group Inc. Is Sinking Today
Shares of MiMedx Group (NASDAQ: MDXG), a biopharmaceutical company focused on regenerative medicine, fell 10% as of 3:45 p.m. EDT on Monday. However, there doesn't appear to be any....
Why DBV Technologies SA Plummeted and Aimmune Therapeutics Inc Skyrocketed Today
DBV Technologies (NASDAQ: DBVT) is down 45% at 12:48 p.m. EDT after announcing that its peanut allergy treatment, Viaskin Peanut, failed -- albeit not by much -- a phase 3 trial. The results....
Why Agenus Inc. Stock Briefly Popped Today
Agenus (NASDAQ: AGEN), a clinical-stage cancer immunotherapy company, saw its shares open up 13% higher Monday on trading volumes nearly six times the daily average. The move came in response to....
A Foolish Take: The Best-Performing S&P 500 Stock This Year
It has been a good year so far for stocks, with the S&P 500 up 15% since the beginning of 2017. But that's just an average of the 500 stocks on the large-cap index; some have done even....
A Foolish Take: The Best-Performing S&P 500 Stock This Year
It has been a good year so far for stocks, with the S&P 500 up 15% since the beginning of 2017. But that's just an average of the 500 stocks on the large-cap index; some have done even....
A Foolish Take: The Best-Performing S&P 500 Stock This Year
It has been a good year so far for stocks, with the S&P 500 up 15% since the beginning of 2017. But that's just an average of the 500 stocks on the large-cap index; some have done even....
3 Gene Therapy Stocks That Could Make You Rich
The FDA just approved another gene-altering cancer treatment that will save thousands of lives. Yescarta from Gilead Sciences (NASDAQ: GILD) teaches cancer patients' immune cells to seek out and....
3 Healthcare Stocks for Your Radar
The healthcare sector is one the most exciting and volatile industries out there, with clinical trial results and administrative changes having the potential to make or break so many companies.....
3 Arguments for and Against Legalizing Marijuana
There's arguably no industry in the U.S. that's growing at a faster, more consistent pace than legal marijuana. Marijuana Business Daily's latest report, "Marijuana Business Factbook 2017,"....
5 Must-Read Quotes for Robotic Surgery Investors
Something big just happened in the robotic surgical industry. Last week, a small company called TransEnterix (NYSEMKT: TRXC) won FDA approval for its Senhance Robotic Surgical System. The....
5 Must-Read Quotes for Robotic Surgery Investors
Something big just happened in the robotic surgical industry. Last week, a small company called TransEnterix (NYSEMKT: TRXC) won FDA approval for its Senhance Robotic Surgical System. The....
5 Must-Read Quotes for Robotic Surgery Investors
Something big just happened in the robotic surgical industry. Last week, a small company called TransEnterix (NYSEMKT: TRXC) won FDA approval for its Senhance Robotic Surgical System. The....
This Marijuana Stock Could Be the Biggest Comeback Story of 2018
Insys Therapeutics (NASDAQ: INSY) is one of the most hated biotech stocks on the market today. That's the case, at least, if you use short interest as a proxy for how much investors hate a given....
Should You Avoid Celgene Stock After Its Big Pipeline Setback?
Even some of the biggest and best have things go wrong every now and then. Celgene (NASDAQ: CELG) has been the best-performing biotech stock over the last five years among big biotechs with market....
5 Key Drugs Critical to Johnson & Johnson's Future
Johnson & Johnson (NYSE: JNJ) recently shared its third-quarter financial report card with investors, and by all measures, it deserves kudos. However, the stock market rewards investors based....
5 Key Drugs Critical to Johnson & Johnson's Future
Johnson & Johnson (NYSE: JNJ) recently shared its third-quarter financial report card with investors, and by all measures, it deserves kudos. However, the stock market rewards investors based....
Robots Power Profits at Intuitive Surgical
Intuitive Surgical (NASDAQ: ISRG) recently provided investors with its third-quarter financial report card, and the company delivered high marks for system placements and sales and procedure....
Robots Power Profits at Intuitive Surgical
Intuitive Surgical (NASDAQ: ISRG) recently provided investors with its third-quarter financial report card, and the company delivered high marks for system placements and sales and procedure....
Robots Power Profits at Intuitive Surgical
Intuitive Surgical (NASDAQ: ISRG) recently provided investors with its third-quarter financial report card, and the company delivered high marks for system placements and sales and procedure....